Jiangxi Synergy Pharmaceutical Co., Ltd.
SHZ: 300636.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhengwei Pang
- Employees
- 1,362
- Headquarters
- Yichun, China
- IPO year
- 2017
- Market cap
- CN¥3.3B
- Website
- https://www.jxsynergy.com
Loading 300636…
Loading profile data…Frequently asked questions about 300636
What does Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ) do?
Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers APIs, liquid crystal compounds, and intermediates. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.
Where does 300636.SZ trade?
Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300636.SZ in?
Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jiangxi Synergy Pharmaceutical Co., Ltd.?
Zhengwei Pang is the chief executive officer of Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ).
Where is Jiangxi Synergy Pharmaceutical Co., Ltd. headquartered?
Jiangxi Synergy Pharmaceutical Co., Ltd. is headquartered in China.
Does 300636.SZ pay a dividend?
Yes — Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ) paid a trailing twelve-month dividend of CNY 0.04 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300636.SZ go public?
Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ) completed its initial public offering in 2017.